![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MILLENIA HOPE GENERATES FIRST AFRICAN MMH MALAREX(TM SALE
MILLENIA HOPE GENERATES FIRST AFRICAN MMH MALAREX(TM SALE
August 11, 2005
Millenia Hope Inc., a Delaware Bio-pharma corporation (OTC Bulletin Board: MLHP; Berlin: MLF), today announced that it has sold, and has received payment of $200,000 for, 25,000 treatments of MMH Malarex(TM)/MMH 18(TM), to a chain of medical clinics in Western Africa. The purchaser also gave a $25,000 deposit for the next 25,000 treatments. This sale is the initial order in a contract that will generate sales of 100,000 treatments over the next 12 months.
eReleases (http://www.ereleases.com/pr/20050810007.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct